Back to LXRX Stock Lookup

LXRX – Analyst Ratings

Dec 6, 2013 07:07 AM BofA/Merrill Lynch Starts Lexicon Pharma (LXRX) at Underperform
Oct 11, 2013 11:50 AM Lexicon Pharma (LXRX) Pullback is Buying Opp, Thinks Gabelli
Jun 11, 2013 06:57 AM Morgan Stanley Downgrades Lexicon Pharmaceuticals (LXRX) to Underweight
May 30, 2013 07:24 AM UPDATE: Jefferies Starts Lexicon Pharmaceuticals (LXRX) at Buy
Aug 1, 2012 08:45 AM Needham & Company Reiterates a 'Buy' on Lexicon Pharmaceuticals (LXRX); Conference Call Takeaways
Jul 18, 2012 11:21 AM Needham & Company Maintains a 'Buy' on Lexicon Pharmaceuticals (LXRX); Big Pipeline Undervalued
Jun 26, 2012 10:53 AM Lexicon Pharma (LXRX) Shares Surge as Stifel Nicolaus Adds to 'Select List,' Boosts Price Target
Jun 22, 2012 07:46 AM Needham & Company Reiterates a 'Buy' on Lexicon Pharmaceuticals (LXRX); LX4211 Phase 2b Trial Data Expected Soon
Jan 6, 2012 10:13 AM Needham & Company Reiterates a 'Buy' on Lexicon Pharmaceuticals (LXRX); 2012 Preview: Several Key Clinical Milestones Anticipated
Dec 23, 2011 07:35 AM Needham & Company 2012 Biotech Preview
Nov 2, 2011 08:20 AM Needham & Company Reiterates a 'Buy' on Lexicon Pharmaceuticals (LXRX); Q3 Review
Sep 22, 2011 02:23 PM Needham & Company Maintains a 'Buy' on Lexicon Pharmaceuticals (LXRX); Underappreciated Given Number of Phase 2 Compounds Under Development
Aug 10, 2011 08:25 AM Needham & Company Reiterates a 'Buy' on Lexicon Pharmaceuticals (LXRX); Encouraging Phase 2 LX1032 Results in Sandostatin-Treated Carcinoid Syndrome Patients
May 27, 2011 07:45 AM Needham & Company Starts Lexicon Pharmaceuticals (LXRX) at Buy; Valuation is Attractive
Apr 25, 2011 04:58 PM Wedbush Starts Lexicon Pharmaceuticals (LXRX) at Outperform; Multiple Shots on Goal Reduces Pipeline Risk
Oct 1, 2010 09:19 AM J.P. Morgan Initiates Coverage on Biotechnology Stocks (LXRX & IMGN)
Jul 30, 2010 10:06 AM Cowen & Co Initiates Coverage on Lexicon Pharmaceuticals (LXRX) with a Neutral
Nov 23, 2009 04:49 PM Thomas Weisel Starts Lexicon (LXRX) at Overweight, $2.50 Price Target
Sep 15, 2009 12:16 PM Piper Says Today's Rally in Lexicon (LXRX) is Overdone; Reiterates Underweight
Oct 29, 2008 08:22 AM Piper Jaffray Downgrades Lexicon Pharmaceuticals (LXRX) to Sell
Sep 8, 2008 07:35 AM Morgan Stanley Downgrades Lexicon Pharmaceuticals (LXRX) to Underweight
Mar 7, 2008 07:54 AM Piper Jaffray downgrades Lexicon Pharmaceuticals (LXRX) to Neutral
May 15, 2007 07:49 AM Banc of America Starts Lexicon Pharmaceuticals (LXRX) at Buy

Back to LXRX Stock Lookup